CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN

Core Viewpoint - China SXT Pharmaceuticals, Inc. is launching an Artificial Intelligence Insight Initiative to enhance the application of AI and digital technologies in the Traditional Chinese Medicine (TCM) raw-material supply chain, aiming to improve supply chain transparency, operational stability, and quality oversight [1][3]. Group 1: AI Initiative Details - The company plans to utilize AI-supported analytical methods in key supply chain areas, including cultivation environment monitoring, origin and authenticity assessment, quality evaluation, and material grading [2]. - China SXT aims to explore AI's potential in supply-demand forecasting and circulation efficiency to support more consistent and data-informed supply chain management [2]. Group 2: Operational Goals - By enhancing digital analytics and process visibility across critical stages of the TCM raw-material supply chain, the company seeks to strengthen traceability, reinforce quality control, and support more reliable resource planning [3]. - The initiative aligns with the company's broader strategy of applying technology to improve overall operational management while preserving traditional TCM production principles [3]. Group 3: Leadership Perspective - Feng Zhou, Co-Chief Executive Officer, emphasized that applying AI to supply chain management is a crucial part of the company's long-term operational planning, aiming to enhance supply chain reliability and strengthen quality assurance capabilities [4].